title: Follow up policy after treatment for Hodgkin's disease: too many clinic visits and routine tests? A review of hospital records.
abstract: OBJECTIVE
  To examine the effectiveness of routine clinic review in detecting relapse after treatment for Hodgkin's disease.
  
  
  METHODS
  Review of hospital records.
  
  
  METHODS
  Regional centre for cancer treatment and research.
  
  
  METHODS
  210 patients with Hodgkin's disease recruited to a chemotherapy trial protocol between 1984 and the end of 1990 who had achieved a complete or partial remission after treatment.
  
  
  METHODS
  The number of clinic visits made by patients over the period of observation, the number of relapses occurring during that time, and the route by which relapse was detected.
  
  
  RESULTS
  The 210 patients generated 2512 outpatient reviews, and 37 relapses were detected. Thirty relapses (81%) were diagnosed in patients who described symptoms, which in 15 cases had resulted in an earlier appointment being arranged. In only four cases (11%; 95% confidence interval 4% to 25%) was relapse detected as a result of routine physical examination on investigation of a patient who did not have symptoms.
  
  
  CONCLUSIONS
  Relapse of Hodgkin's disease after treatment is usually detected as a result of the investigation of symptoms rather than by routine screening of asymptomatic patients. It is therefore proposed that the frequency of routine follow up visits should be reduced and greater emphasis placed on patient education. This should underline the importance of symptoms and encourage patients to arrange an earlier appointment if these develop.
authors.affiliation: Department of Medical Oncology, Christie Hospital NHS Trust, Manchester.
authors.forename: J A
authors.initials: JA
authors.lastname: Radford
authors.forename: A
authors.initials: A
authors.lastname: Eardley
authors.forename: C
authors.initials: C
authors.lastname: Woodman
authors.forename: D
authors.initials: D
authors.lastname: Crowther
mesh_terms: D000553:Ambulatory Care; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002173:Cancer Care Facilities; D004739:England; D005500:Follow-Up Studies; D006291:Health Policy; D006689:Hodgkin Disease / Q000188:drug therapy*; D006779:Hospitals, Public / Q000706:statistics & numerical data; D006801:Humans; D016134:Organizational Policy; D010044:Outpatient Clinics, Hospital / Q000706:statistics & numerical data*; D010808:Physical Examination; D012008:Recurrence; D012017:Referral and Consultation; D012307:Risk Factors; D019564:Unnecessary Procedures